Richard A Zager MD
Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
Harborview Medical Center325 9TH AveSeattle, WA 98104
Phone+1 206-731-3000
Are you Dr. Zager?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Zager, MD is a nephrologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Ohio. He is a Professor at University of Washington School of Medicine.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1976 - 1977
Boston University Medical CenterResidency, Internal Medicine, 1975 - 1976
University of WashingtonResidency, Internal Medicine, 1973 - 1974
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1970 - 1971
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1969 - 1970
Northwestern University The Feinberg School of MedicineClass of 1969
Certifications & Licensure
WA State Medical License 1973 - 2025
OH State Medical License 1980 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 3 citationsOxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.Richard A Zager
Physiological Reports. 2022-10-01 - 5 citationsEarly loss of glutathione -s- transferase (GST) activity during diverse forms of acute renal tubular injury.Richard A Zager, Ali C M Johnson
Physiological Reports. 2022-06-01 - 6 citationsCatalytic iron mediated renal stress responses during experimental cardiorenal syndrome 1 ("CRS-1").Ali C.M. Johnson, Richard A. Zager
Translational Research. 2021-07-01
Press Mentions
Renibus Therapeutics Announces Publication of Positive Results of RBT-3 Experimental Preclinical Studies in Scientific Journal Nephrology Dialysis TransplantFebruary 16th, 2021- Renibus Therapeutics Announces Publication of a Novel Stress Test for Assessing Antioxidant Defenses in Chronic Kidney DiseaseJune 16th, 2020
- Renibus Therapeutics Announces Abstract Presentation at the 2020 European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Annual CongressJune 9th, 2020
